Close

ELAVL4

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

ELAVL4 (ELAV Like RNA Binding Protein 4) is a Protein Coding gene. Diseases associated with ELAVL4 include Hallucinogen Abuse and Paraneoplastic Neurologic Disorders. Gene Ontology (GO) annotations related to this gene include nucleic acid binding and nucleotide binding. An important paralog of this gene is ELAVL2.
  • CAR Vector Products

  • TCR Vector Products

  • TCR Cell Products

  • TCR Viral Particles

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-YC0102 Anti-ELAVL4 (232) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Human 232 Human scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0103 Anti-ELAVL4 (XHM158) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Human XHM158 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0104 Anti-ELAVL4 (6B9) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Human 6B9 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC1002 Anti-ELAVL4 (232) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Human 232 Human scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC1003 Anti-ELAVL4 (XHM158) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Human XHM158 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC1004 Anti-ELAVL4 (6B9) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Human 6B9 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY0204 Anti-ELAVL4 (CBFYE-0198) h(41BB-CD3ζ) CAR, pCDCAR1 Human, Rat CBFYE-0198 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY3457 Anti-ELAVL4 (CBFYE-0198) h(CD28-CD3ζ) CAR, pCDCAR1 Human, Rat CBFYE-0198 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.